Page last updated: 2024-09-05

dabigatran and Cardiovascular Stroke

dabigatran has been researched along with Cardiovascular Stroke in 92 studies

Research

Studies (92)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (3.26)	29.6817
2010's	77 (83.70)	24.3611
2020's	12 (13.04)	2.80

Authors

Authors	Studies
Alioğlu, E; Altın, C; Bilgin, N; Çetin, N; Dalgıç, O; Ekmekçi, C; Kocabaş, U; Özpelit, ME; Pekel, N; Topaloğlu, C; Tülüce, K; Tunçer, E; Türk, UÖ; Türkoğlu, Eİ; Yavuz, V; Yüksel, K	1
Bartels, DB; Diener, HC; Dubner, SJ; Gurusamy, VK; Halperin, JL; Huisman, MV; Lip, GYH; Lohmann, R; Lu, S; Ma, CS; Rothman, KJ; Teutsch, C	1
Diener, HC; Dubner, SJ; Gurusamy, VK; Halperin, JL; Huisman, MV; Kotalczyk, A; Lip, GYH; Ma, CS; Marler, S; Rothman, KJ; Teutsch, C	1
Ali, AK; Duffield, S; Gatto, N; Gibbs, L; Govil, P; Jaksa, A; Jonsson, P; Kent, S; Kincaid, L; Patrick, AR; Rowark, S; Sharma, M	1
Agustsson, AS; Bjornsson, ES; Gudmundsdottir, BR; Hreinsson, JP; Ingason, AB; Lund, SH; Onundarson, PT; Palsson, DA; Reynisson, IE; Rumba, E	1
Albendín Iglesias, H; Arregui Montoya, F; Bailén Lorenzo, JL; Caro Martínez, C; Cerezo Manchado, JJ; Elvira Ruiz, G; Flores Blanco, PJ; García Alberola, A; Lova Navarro, A; Manzano-Fernández, S; Pascual Figal, DA	1
Blin, P; de Pouvourville, G; Karam, P	1
Bartels, DB; Diener, HC; Dubner, SJ; França, LR; Halperin, JL; Huisman, MV; Lip, GYH; Lu, S; Ma, CS; Mazurek, M; Paquette, M; Rothman, KJ; Teutsch, C; Zint, K	1
Ashley, J; Badve, SV; Battistella, M; Bota, S; Garg, AX; Harel, Z; Jun, M; Manuel, D; Mavrakanas, T; McArthur, E; Molnar, AO; Rhodes, E; Sood, MM; Tanuseputro, P; Wells, P	1
Goya, M; Hirao, K; Kawabata, M; Maeda, S; Sasano, T; Takahashi, Y; Yagishita, A	1
Chiu, D; Weinberger, J	1
Del Sole, F; Menichelli, D; Pastori, D; Pignatelli, P; Violi, F	1
Di Fusco, M; Friend, K; Jones, WS; Keshishian, A; Li, X; Lopes, RD; Luo, X; Mardekian, J; Masseria, C; Pan, X; Thomas, L; Yuce, H	1
Burden, AM; de Boer, A; de Vries, F; Ebbelaar, C; Schalekamp, T; Souverein, P; Stolk, LM; Ten Cate-Hoek, A	1
Chan, KA; Chen, HM; Lai, CL; Liao, MT; Lin, TT	1
Lip, GYH; Makaritsis, K; Michel, P; Ntaios, G; Papavasileiou, V; Vemmos, K	1
Bhave, PD; Bhise, V; Chaikriangkrai, K; Deshmukh, A; Giudici, M; Horwitz, PA; Inampudi, C; Kumar, AA; Mentias, A; Mickelsen, S; Oral, H; Palamaner Subash Shantha, G; Pancholy, S; Patel, N; Vaughan Sarrazin, MS	1
Li, H; Ma, C; Sheng, J; Song, K; Wang, Y	1
Cheetham, TC; Gagne, JJ; Go, AS; Goulding, MR; Graham, DJ; Houstoun, M; Izem, R; Mott, K; Reichman, ME; Singer, DE; Southworth, MR; Sung, SH; Toh, S; Zhang, R	1
Elder, J; Fu, AC; Jain, R; Lim, J; Sander, SD; Tan, H; Wang, C	1
Bangdiwala, SI; Berwanger, O; Biccard, BM; Botto, F; Chaudhry, NK; Connolly, SJ; de Nadal, M; Devereaux, PJ; Duceppe, E; Eikelboom, JW; Franzosi, MG; Guyatt, G; Kearon, C; Magloire, P; Mayosi, B; Meyhoff, CS; Neary, J; Parlow, J; Pettit, S; Popova, E; Rao, M; Rodseth, R; Sessler, DI; Sharma, M; Srinathan, SK; Szczeklik, W; Tandon, V; Villar, JC; Vincent, J; Xavier, D; Yusuf, S	1
Leow, AS; Loh, JP; Sia, CH; Tan, BY	1
Ding, YF; Gu, ZC; Li, J; Lin, HW; Liu, D; Liu, XY; Pu, J; Wei, AH; Zhang, C	1
Baser, O; Di Fusco, M; Friend, K; Gupta, K; Hamilton, M; Jones, WS; Keshishian, A; Li, X; Lopes, RD; Luo, X; Mardekian, J; Masseria, C; Pan, X; Steffel, J	1
Bangdiwala, SI; Berwanger, O; Biccard, BM; Botto, F; Chaudhry, NK; Connolly, SJ; de Nadal, M; Devereaux, PJ; Duceppe, E; Eikelboom, JW; Erb, J; Franzosi, MG; Guyatt, G; Hoeft, A; Iglesias, PP; Kearon, C; Magloire, P; Mayosi, B; Meyhoff, CS; Neary, J; Pettit, S; Rahate, PV; Rao, M; Rao-Melacini, P; Rodseth, R; Sessler, DI; Sharma, M; Srinathan, SK; Szczeklik, W; Tandon, V; Villar, JC; Vincent, J; Xavier, D; Yusuf, S	1
Eikelboom, JW; Hohnloser, SH	1
Gu, ZC; Pu, J; Wei, AH	1
Chen, XH; Zhao, HL	1
Dannenberg, L; Kelm, M; Petzold, T; Polzin, A; Wolff, G; Zeus, T	1
Agnelli, G; Aita, A; Angeli, F; Becattini, C; Cavallini, C; Conti, S; Giustozzi, M; Molini, G; Turturiello, D; Vedovati, MC; Verdecchia, P	1
Bates, ER	1
Alcusky, M; Fisher, M; Goldberg, RJ; Hume, AL; Lapane, KL; McManus, DD; Tjia, J	1
Gottsäter, A	1
DuCott, A; Gagne, JJ; Maro, JC; Petrone, AB; Toh, S	1
Caughey, G; Duszynski, K; Kalisch Ellett, LM; Kerr, M; Pratt, NL; Ramsay, E; Roughead, EE; Shakib, S	1
López-López, JA; Thom, H; Welton, NJ	1
Bergh, M; Marais, CA; Miller-Jansön, H; Salie, F; Stander, MP	1
Christory, F; Connolly, SJ; Dan, GA; Hatala, R; Huber, K; Kher, A; Kiss, RG; Klun, NV; Meier, B; Merkely, B; Pieske, B; Potpara, T; Stępińska, J; Vinereanu, D; Widimský, P	1
Callréus, T; Due, KM; Larsen, TB; Lip, GY; Rasmussen, LH; Rosenzweig, M; Skjøth, F	1
Attia, JR; Pearce, R	1
Eikelboom, JW; Hankey, GJ	1
Shavadia, J; Welsh, RC	1
Artang, R; Nielsen, JD; Rome, E; Vidaillet, HJ	1
Clemens, A; Fraessdorf, M; Friedman, J	1
Basile, E; Di Biase, L; Giglio, AF; Natale, A; Santangeli, P; Trotta, F	1
Acket, B; Bagheri, H; Bourrel, R; Lavezzi, O; Molinier, A; Montastruc, JL	1
Larsen, TB; Lip, GY; Rasmussen, LH; Skjøth, F	1
Iung, B; Vahanian, A	1
Barón, AE; Bradley, SM; Carey, EP; Cunningham, F; Grunwald, GK; Ho, PM; Jackevicius, CA; Maddox, TM; Marzec, LN; Pilote, L; Rumsfeld, JS; Schneider, PM; Shore, S; Turakhia, MP; Varosy, PD	1
Bruyère, O; Buckinx, F; Dogné, JM; Douxfils, J; Hainaut, P; Minet, V; Mullier, F; Rabenda, V; Reginster, JY	1
Marciniak, ET; McCurdy, MT; Reed, RM; Weiler, B	1
Rudakova, AV; Tatarskiĭ, BA	1
Fosbøl, EL; Gislason, GH; Hansen, ML; Køber, L; Lamberts, M; Mikkelsen, AP; Olesen, JB; Sørensen, R; Torp-Pedersen, C; Weeke, P	1
Amin, A; Bruno, A; Lin, J; Lingohr-Smith, M; Trocio, J	1
Bultas, J	1
Brookhart, MA; Fang, G; Farley, JF; Gehi, AK; Lauffenburger, JC; Rhoney, DH	1
Cattaneo, M; Lussana, F; Squizzato, A	1
Crawford, B; Morimoto, T; Ueda, S; Wada, K	1
Amioka, M; Fujiwara, M; Kaseda, S; Ohashi, N; Okada, T; Uchida, M	1
Angelopoulou, SM; Bouziana, SD; Giampatzis, V; Hatzitolios, AI; Konstantara, F; Kostaki, S; Papadopoulou, M; Savopoulos, C; Spanou, M; Tziomalos, K	1
Collins, J; Fraeman, K; Reynolds, MW; Schnee, J; Schwartzman, E; Siu, K; Villines, TC	1
Bartels, DB; Bykov, K; Huybrechts, K; Schneeweiss, S; Seeger, JD; Zint, K	1
Andersson, U; Aulin, J; Connolly, SJ; Ezekowitz, MD; Hijazi, Z; Huber, K; Oldgren, J; Reilly, PA; Siegbahn, A; Wallentin, L	1
Chan, YH; Chang, SH; Kuo, CT; Lee, HF; See, LC; Tu, HT; Wu, LS; Yeh, YH; Yen, KC	1
Caldeira, D; Costa, J; Ferreira, JJ; Pinto, FJ	1
Aksoy, H; Ata, N; Ayturk, M; Dal, K; Ozkan, S; Ozturk, M; Şabanoglu, C; Tanalp, AC; Topaloglu, C; Yavuz, B; Yavuz, BB	1
Carmo, J; Ferreira, J; Mendes, M; Moscoso Costa, F	1
Bhatt, DL; Blatchford, J; Brueckmann, M; Cannon, CP; Ellis, SG; Ferreiros Ripoll, E; Gropper, S; Hohnloser, SH; Kimura, T; Kreuzer, J; Lip, GY; Manassie, J; Massaro, JM; Oldgren, J; Steg, PG; Ten Berg, JM	1
Angoulvant, D; Babuty, D; Bejan-Angoulvant, T; Darwiche, W; Fauchier, L	1
Butala, NM; Kartoun, U; Kennedy, KF; Mahmood, S; Secemsky, EA; Shaw, SY; Wasfy, JH; Yeh, RW	1
Alonso, A; Bengtson, LGS; Chen, LY; Lutsey, PL; MacLehose, RF	1
Guo, L; Hong, Y; Li, S; Wang, P; Zhong, X	1
Achilles, A; Dannenberg, L; Fischer, JW; Grandoch, M; Hohlfeld, T; Kelm, M; Levkau, B; Mohring, A; Polzin, A; Zeus, T	1
Eriksson, H; Feuring, M; Goldhaber, SZ; Hantel, S; Kakkar, AJ; Kreuzer, J; Schellong, S; Schueler, E; Schulman, S	1
Alings, M; Connolly, SJ; Darius, H; Diaz, R; Diener, HC; Eikelboom, J; Ezekowitz, MD; Joyner, CD; Lewis, BS; Oldgren, J; Parekh, A; Pogue, J; Reilly, PA; Themeles, E; Varrone, J; Wallentin, L; Wang, S; Xavier, D; Yusuf, S; Zhu, J	1
Tomoda, H	1
Christersson, C; Johnell, M; Siegbahn, A	1
Lane, DA; Lip, GY	1
Freeman, JV; Garber, AM; Go, AS; Hutton, DW; Owens, DK; Turakhia, MP; Wang, PJ; Zhu, RP	1
Connolly, SJ; Ezekowitz, MD; Reilly, PA; Wallentin, L; Yusuf, S	1
Budaj, A; Granger, CB; Khder, Y; Oldgren, J; Roberts, J; Siegbahn, A; Tijssen, JG; Van de Werf, F; Wallentin, L	1
Bode, C; Moser, M	1
Diener, HC; Eikelboom, JW; Hohnloser, SH; Weimar, C	1
Redberg, RF	1
Jacobs, JM; Stessman, J	1
Hernandez, AV; Uchino, K	1
Mullard, A	1
Bergholdt Asmussen, M; Langkilde, LK; Overgaard, M	1
Diener, HC; Harenberg, J; Lip, GY; Marder, VJ; Marx, S; Wehling, M; Weiss, C	1
Connolly, SJ; Coppens, M; Dale, B; Eikelboom, JW; Ginsberg, JS; Hirsh, J; Paikin, JS; Weitz, JI; Whitlock, RP; Young, E	1
Eikelboom, JW; Hirsh, J; O'Donnell, M	1

Reviews

21 review(s) available for dabigatran and Cardiovascular Stroke

Article	Year
Real-World Setting Comparison of Nonvitamin-K Antagonist Oral Anticoagulants Versus Vitamin-K Antagonists for Stroke Prevention in Atrial Fibrillation: A Systematic Review and Meta-Analysis. Stroke, 2017, Volume: 48, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Brain Ischemia; Dabigatran; Gastrointestinal Hemorrhage; Hemorrhage; Humans; Myocardial Infarction; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Warfarin	2017
A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus. Journal of thrombosis and thrombolysis, 2018, Volume: 46, Issue:1 Topics: Administration, Oral; Anticoagulants; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Pyrazoles; Pyridones; Rivaroxaban; Thrombosis; Ventricular Dysfunction, Left	2018
Increased risk of myocardial infarction with dabigatran etexilate: fact or fiction? A critical meta-analysis of over 580,000 patients from integrating randomized controlled trials and real-world studies. International journal of cardiology, 2018, Sep-15, Volume: 267 Topics: Anticoagulants; Dabigatran; Drug-Related Side Effects and Adverse Reactions; Humans; Myocardial Infarction; Observational Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors	2018
Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation. International journal of clinical practice, 2013, Volume: 67, Issue:6 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Interactions; Dyspepsia; Electric Countershock; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Pyridines; Randomized Controlled Trials as Topic; Stents; Stroke; Treatment Outcome	2013
Meta-analysis of randomized controlled trials on risk of myocardial infarction from the use of oral direct thrombin inhibitors. The American journal of cardiology, 2013, Dec-15, Volume: 112, Issue:12 Topics: Amidines; Anticoagulants; Antithrombins; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Stroke; Warfarin	2013
Cardiovascular outcomes during treatment with dabigatran: comprehensive analysis of individual subject data by treatment. Vascular health and risk management, 2013, Volume: 9 Topics: Acute Coronary Syndrome; Antithrombins; Atrial Fibrillation; Benzimidazoles; Chi-Square Distribution; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Humans; Myocardial Infarction; Odds Ratio; Pyridines; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Venous Thromboembolism; Warfarin	2013
Increased risk of myocardial infarction with dabigatran: fact or fiction? Journal of cardiovascular medicine (Hagerstown, Md.), 2014, Volume: 15, Issue:1 Topics: Acute Coronary Syndrome; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Risk Assessment; Risk Factors; Stroke; Treatment Outcome; Venous Thromboembolism	2014
Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials. Journal of the American Heart Association, 2014, Jun-06, Volume: 3, Issue:3 Topics: Benzimidazoles; Cardiovascular Diseases; Dabigatran; Factor Xa Inhibitors; Hemorrhage; Humans; Mortality; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Risk Factors; Venous Thromboembolism	2014
[Anticoagulant therapy in secondary prevention of coronary events]. Vnitrni lekarstvi, 2014, Volume: 60, Issue:12 Topics: Acute Coronary Syndrome; Administration, Oral; Anticoagulants; Aspirin; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Clopidogrel; Dabigatran; Hemorrhage; Humans; Morpholines; Myocardial Infarction; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyrazoles; Pyridones; Rivaroxaban; Secondary Prevention; Thiophenes; Ticlopidine; Warfarin	2014
Post-operative arterial thrombosis with non-vitamin K antagonist oral anticoagulants after total hip or knee arthroplasty. Thrombosis and haemostasis, 2015, Volume: 114, Issue:2 Topics: Aged; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Brain Ischemia; Clinical Trials, Phase III as Topic; Dabigatran; Enoxaparin; Factor Xa Inhibitors; Female; Humans; Incidence; Male; Middle Aged; Multicenter Studies as Topic; Myocardial Infarction; Postoperative Complications; Postoperative Hemorrhage; Prothrombin; Pulmonary Embolism; Pyrazoles; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Treatment Outcome	2015
Comparative efficacy and safety of novel oral anticoagulants in patients with atrial fibrillation: A network meta-analysis with the adjustment for the possible bias from open label studies. Journal of cardiology, 2015, Volume: 66, Issue:6 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Azetidines; Benzylamines; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Odds Ratio; Oligosaccharides; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Thiazoles; Thromboembolism; Treatment Outcome; Vitamin K	2015
Safety of non-vitamin K antagonist oral anticoagulants - coronary risks. Expert opinion on drug safety, 2016, Volume: 15, Issue:6 Topics: Administration, Oral; Anticoagulants; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic; Risk	2016
Dabigatran in real-world atrial fibrillation. Meta-analysis of observational comparison studies with vitamin K antagonists. Thrombosis and haemostasis, 2016, Sep-27, Volume: 116, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Observational Studies as Topic; Stroke; Vitamin K	2016
Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analyses. Thrombosis and haemostasis, 2016, Nov-30, Volume: 116, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Humans; Myocardial Infarction; Observational Studies as Topic; Risk Assessment; Vitamin K	2016
Comparative Efficacy of Clinical Events Prevention of Five Anticoagulants in Patients With Atrial Fibrillation (A Network Meta-Analysis). The American journal of cardiology, 2017, Feb-15, Volume: 119, Issue:4 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Mortality; Myocardial Infarction; Network Meta-Analysis; Odds Ratio; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; Warfarin	2017
Does warfarin for stroke thromboprophylaxis protect against MI in atrial fibrillation patients? The American journal of medicine, 2010, Volume: 123, Issue:9 Topics: Anticoagulants; Atrial Fibrillation; Azetidines; Benzimidazoles; Benzylamines; Biphenyl Compounds; Dabigatran; Humans; Irbesartan; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Stroke; Tetrazoles; Warfarin	2010
Preventing cardioembolic stroke in atrial fibrillation with dabigatran. Current neurology and neuroscience reports, 2012, Volume: 12, Issue:1 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials as Topic; Dabigatran; Embolism; Hemorrhage; Humans; Myocardial Infarction; Stroke; Warfarin	2012
Dabigatran association with higher risk of acute coronary events: meta-analysis of noninferiority randomized controlled trials. Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Adult; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Prognosis; Randomized Controlled Trials as Topic; Risk Assessment; Thromboembolism	2012
Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients. Prescrire international, 2012, Volume: 21, Issue:124 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; International Normalized Ratio; Liver; Myocardial Infarction; Warfarin	2012
Comparison of efficacy and safety of dabigatran, rivaroxaban and apixaban in patients with atrial fibrillation using network meta-analysis. International angiology : a journal of the International Union of Angiology, 2012, Volume: 31, Issue:4 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cerebral Hemorrhage; Chi-Square Distribution; Dabigatran; Embolism; Female; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Odds Ratio; Pyrazoles; Pyridones; Risk Assessment; Risk Factors; Rivaroxaban; Stroke; Thiophenes; Treatment Outcome	2012
Beyond unfractionated heparin and warfarin: current and future advances. Circulation, 2007, Jul-31, Volume: 116, Issue:5 Topics: Angina, Unstable; Anticoagulants; Azetidines; Benzimidazoles; Benzylamines; Brain Ischemia; Clinical Trials as Topic; Coumarins; Dabigatran; Factor Xa Inhibitors; Fibrinolytic Agents; Fondaparinux; Forecasting; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Morpholines; Myocardial Infarction; Peptide Fragments; Polysaccharides; Prothrombin; Pyrazoles; Pyridines; Pyridones; Recombinant Proteins; Rivaroxaban; Thiophenes; Thrombin; Thrombophilia; Thrombosis; Warfarin	2007

Trials

7 trial(s) available for dabigatran and Cardiovascular Stroke

Article	Year
Design of a Randomized Placebo-Controlled Trial to Assess Dabigatran and Omeprazole in Patients with Myocardial Injury after Noncardiac Surgery (MANAGE). The Canadian journal of cardiology, 2018, Volume: 34, Issue:3 Topics: Aged; Cause of Death; Dabigatran; Double-Blind Method; Female; Follow-Up Studies; Humans; Internationality; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Omeprazole; Postoperative Complications; Proportional Hazards Models; Risk Assessment; Surgical Procedures, Operative; Survival Analysis; Treatment Outcome	2018
Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial. Lancet (London, England), 2018, 06-09, Volume: 391, Issue:10137 Topics: Aged; Aged, 80 and over; Antithrombins; Dabigatran; Female; Hemorrhage; Humans; Male; Myocardial Infarction; Omeprazole; Perioperative Period; Peripheral Arterial Disease; Placebo Effect; Proton Pump Inhibitors; Stroke; Thrombosis; Treatment Outcome; Troponin; Venous Thromboembolism	2018
Interleukin-6 and C-reactive protein and risk for death and cardiovascular events in patients with atrial fibrillation. American heart journal, 2015, Volume: 170, Issue:6 Topics: Aged; Anticoagulants; Atrial Fibrillation; Biomarkers; C-Reactive Protein; Dabigatran; Female; Hemorrhage; Humans; Interleukin-6; Male; Myocardial Infarction; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Risk Assessment; Stroke; Thromboembolism; Warfarin	2015
Design and Rationale of the RE-DUAL PCI Trial: A Prospective, Randomized, Phase 3b Study Comparing the Safety and Efficacy of Dual Antithrombotic Therapy With Dabigatran Etexilate Versus Warfarin Triple Therapy in Patients With Nonvalvular Atrial Fibrilla Clinical cardiology, 2016, Volume: 39, Issue:10 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Clinical Protocols; Coronary Artery Disease; Coronary Thrombosis; Dabigatran; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Research Design; Risk Factors; Stents; Stroke; Time Factors; Treatment Outcome; Warfarin	2016
Dabigatran versus warfarin in patients with atrial fibrillation. The New England journal of medicine, 2009, Sep-17, Volume: 361, Issue:12 Topics: Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; Chi-Square Distribution; Dabigatran; Double-Blind Method; Dyspepsia; Embolism; Female; Follow-Up Studies; Hemorrhage; Humans; Liver; Male; Middle Aged; Myocardial Infarction; Prodrugs; Proportional Hazards Models; Pyridines; Stroke; Warfarin	2009
Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double-blind, phase II trial. European heart journal, 2011, Volume: 32, Issue:22 Topics: Acute Coronary Syndrome; Aged; Aspirin; Benzimidazoles; beta-Alanine; Clopidogrel; Dabigatran; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fibrin Fibrinogen Degradation Products; Fibrinolytic Agents; Hemorrhage; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Recurrence; Ticlopidine; Treatment Outcome	2011
Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? Journal of thrombosis and thrombolysis, 2013, Volume: 35, Issue:2 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Thrombin; Warfarin	2013

Other Studies

64 other study(ies) available for dabigatran and Cardiovascular Stroke

Article	Year
Dabigatran for stroke prevention in real life in a sample of population from Turkey: D-SPIRIT registry. Turk Kardiyoloji Dernegi arsivi : Turk Kardiyoloji Derneginin yayin organidir, 2021, Volume: 49, Issue:8 Topics: Age Factors; Aged; Antithrombins; Atrial Fibrillation; Cause of Death; Dabigatran; Diabetes Mellitus; Embolism; Female; Heart Failure; Hemorrhage; Humans; Hypertension; Ischemic Attack, Transient; Male; Myocardial Infarction; Product Surveillance, Postmarketing; Prospective Studies; Registries; Sex Factors; Stroke; Thromboembolism; Turkey	2021
Dabigatran versus vitamin K antagonists for atrial fibrillation in clinical practice: final outcomes from Phase III of the GLORIA-AF registry. Clinical research in cardiology : official journal of the German Cardiac Society, 2022, Volume: 111, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Myocardial Infarction; Prospective Studies; Registries; Stroke; Vitamin K	2022
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry. Clinical research in cardiology : official journal of the German Cardiac Society, 2022, Volume: 111, Issue:5 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Clinical Trials, Phase III as Topic; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Prospective Studies; Pyridones; Registries; Rivaroxaban; Stroke	2022
Using primary care data to assess comparative effectiveness and safety of apixaban and rivaroxaban in patients with nonvalvular atrial fibrillation in the UK: an observational cohort study. BMJ open, 2022, 10-17, Volume: 12, Issue:10 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Hemorrhage; Humans; Ischemic Attack, Transient; Myocardial Infarction; Primary Health Care; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United Kingdom; Warfarin	2022
Comparison of the effectiveness and safety of direct oral anticoagulants: a nationwide propensity score-weighted study. Blood advances, 2023, 06-13, Volume: 7, Issue:11 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Propensity Score; Rivaroxaban; Stroke	2023
Effect of concomitant antiplatelet therapy in patients with nonvalvular atrial fibrillation initiating non-vitamin K antagonists. European journal of clinical investigation, 2019, Volume: 49, Issue:10 Topics: Aged; Aged, 80 and over; Antithrombins; Aspirin; Atrial Fibrillation; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Female; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Purinergic P2Y Receptor Antagonists; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; Thiazoles	2019
The contribution of real-world evidence to cost-effectiveness analysis: case study of Dabigatran etexilate in France. The European journal of health economics : HEPAC : health economics in prevention and care, 2020, Volume: 21, Issue:2 Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Dabigatran; France; Hemorrhage; Humans; Myocardial Infarction; Quality-Adjusted Life Years; Rivaroxaban; Stroke; Warfarin	2020
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program. American heart journal, 2019, Volume: 218 Topics: Antithrombins; Atrial Fibrillation; Cause of Death; Cohort Studies; Dabigatran; Follow-Up Studies; Hemorrhage; Humans; Incidence; Myocardial Infarction; Prospective Studies; Registries; Stroke; Time Factors; Treatment Outcome	2019
Risk of Cardiovascular Events and Mortality Among Elderly Patients With Reduced GFR Receiving Direct Oral Anticoagulants. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2020, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Antithrombins; Brain Ischemia; Cause of Death; Comorbidity; Dabigatran; Female; Glomerular Filtration Rate; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Myocardial Revascularization; Ontario; Procedures and Techniques Utilization; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Renal Insufficiency, Chronic; Retrospective Studies; Rivaroxaban; Thrombophilia; Vitamin K	2020
A Survey of Direct Oral Anticoagulant Cessation in General Surgery and Outcomes in Patients with Nonvalvular Atrial Fibrillation. International heart journal, 2020, Sep-29, Volume: 61, Issue:5 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Loss, Surgical; Carotid Artery Diseases; Cerebral Infarction; Dabigatran; Digestive System Surgical Procedures; Elective Surgical Procedures; Embolism; Endoscopy; Factor Xa Inhibitors; Female; Humans; Male; Myocardial Infarction; Orthopedic Procedures; Perioperative Care; Postoperative Complications; Postoperative Hemorrhage; Pyrazoles; Pyridines; Pyridones; Retrospective Studies; Rivaroxaban; Thiazoles; Thromboembolism; Urologic Surgical Procedures; Vascular Surgical Procedures	2020
Cerebral Venous Sinus Thrombosis and Acute Myocardial Infarction in a Patient with PAI-1 4G/4G Homozygosity. Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2020, Volume: 29, Issue:11 Topics: Adult; Anticoagulants; Antithrombins; Dabigatran; Drug Substitution; Genetic Predisposition to Disease; Hemostasis; Heparin; Homozygote; Humans; Male; Myocardial Infarction; Phenotype; Plasminogen Activator Inhibitor 1; Sinus Thrombosis, Intracranial; Time Factors; Treatment Failure; Warfarin	2020
Long-Term Risk of Major Adverse Cardiac Events in Atrial Fibrillation Patients on Direct Oral Anticoagulants. Mayo Clinic proceedings, 2021, Volume: 96, Issue:3 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Heart Failure; Humans; Male; Medication Adherence; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Prospective Studies; Rivaroxaban	2021
Clinical and Economic Outcomes Among Nonvalvular Atrial Fibrillation Patients With Coronary Artery Disease and/or Peripheral Artery Disease. The American journal of cardiology, 2021, 06-01, Volume: 148 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cause of Death; Coronary Artery Disease; Dabigatran; Embolism; Female; Health Care Costs; Hemorrhage; Humans; Male; Mortality; Myocardial Infarction; Peripheral Arterial Disease; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Rivaroxaban; Stroke; United States; Warfarin	2021
Risk of myocardial infarction in patients with atrial fibrillation using vitamin K antagonists, aspirin or direct acting oral anticoagulants. British journal of clinical pharmacology, 2017, Volume: 83, Issue:8 Topics: Administration, Oral; Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Dabigatran; Female; Fibrinolytic Agents; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Retrospective Studies; Risk Factors; Rivaroxaban; Stroke; Vitamin K	2017
Comparative Effectiveness and Safety of Dabigatran and Rivaroxaban in Atrial Fibrillation Patients. Journal of the American Heart Association, 2017, Apr-24, Volume: 6, Issue:4 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Blood Transfusion; Cause of Death; Comparative Effectiveness Research; Dabigatran; Embolism; Factor Xa Inhibitors; Female; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Logistic Models; Male; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Stroke	2017
Sex-Specific Associations of Oral Anticoagulant Use and Cardiovascular Outcomes in Patients With Atrial Fibrillation. Journal of the American Heart Association, 2017, Aug-18, Volume: 6, Issue:8 Topics: Administration, Oral; Administrative Claims, Healthcare; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cause of Death; Chi-Square Distribution; Dabigatran; Databases, Factual; Female; Heart Failure; Humans; Kaplan-Meier Estimate; Male; Medicare; Multivariate Analysis; Myocardial Infarction; Patient Admission; Propensity Score; Proportional Hazards Models; Retrospective Studies; Risk Factors; Rivaroxaban; Sex Factors; Time Factors; Treatment Outcome; United States; Warfarin	2017
Effects of dabigatran regulates no‑reflow phenomenon in acute myocardial infarction mice through anti‑inflammatory and anti‑oxidative activities and connective tissue growth factor expression. Molecular medicine reports, 2018, Volume: 17, Issue:1 Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Blood Pressure; Connective Tissue Growth Factor; Dabigatran; Gene Expression; Mice; Myocardial Infarction; No-Reflow Phenomenon; Oxidative Stress; Rabbits; Transforming Growth Factor beta1	2018
Outcomes of Dabigatran and Warfarin for Atrial Fibrillation in Contemporary Practice: A Retrospective Cohort Study. Annals of internal medicine, 2017, Dec-19, Volume: 167, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Female; Hemorrhage; Humans; Incidence; Male; Middle Aged; Myocardial Infarction; Propensity Score; Retrospective Studies; Stroke; Warfarin	2017
Health Care Resource Utilization and Costs Among Newly Diagnosed and Oral Anticoagulant-Naive Nonvalvular Atrial Fibrillation Patients Treated with Dabigatran or Warfarin in the United States. Journal of managed care & specialty pharmacy, 2018, Volume: 24, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Health Care Costs; Hemorrhage; Hospitalization; Humans; International Normalized Ratio; Male; Middle Aged; Myocardial Infarction; Patient Acceptance of Health Care; Retrospective Studies; Stroke; United States; Warfarin	2018
Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. The American journal of medicine, 2018, Volume: 131, Issue:9 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Coronary Artery Disease; Dabigatran; Embolism; Female; Hemorrhage; Humans; Male; Medicare; Myocardial Infarction; Peripheral Arterial Disease; Proportional Hazards Models; Pyrazoles; Pyridones; Retrospective Studies; Rivaroxaban; Stroke; United States; Warfarin	2018
Direct Oral Anticoagulants and Myocardial Infarction: The Dust Is Settling. Journal of the American College of Cardiology, 2018, 07-03, Volume: 72, Issue:1 Topics: Anticoagulants; Atrial Fibrillation; Dabigatran; Dust; Humans; Myocardial Infarction	2018
Response to comments of manuscript: Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer? International journal of cardiology, 2018, 11-01, Volume: 270 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Warfarin; Wine	2018
Association between dabigatran etexilate and risk of myocardial infarction. International journal of cardiology, 2019, 03-15, Volume: 279 Topics: Antithrombins; Dabigatran; Humans; Myocardial Infarction; Randomized Controlled Trials as Topic	2019
Increased risk of myocardial infarction with dabigatran etexilate: Fact or fiction? A critical meta-analysis from integrating randomized controlled trials and real-world studies: Wine or spritzer? International journal of cardiology, 2018, 11-01, Volume: 270 Topics: Anticoagulants; Antithrombins; Atrial Fibrillation; Dabigatran; Humans; Myocardial Infarction; Pyridines; Randomized Controlled Trials as Topic; Stroke; Warfarin; Wine	2018
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study. Expert opinion on drug safety, 2018, Volume: 17, Issue:11 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Follow-Up Studies; Hemorrhage; Humans; Italy; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Stroke; Thromboembolism; Treatment Outcome	2018
In myocardial injury after noncardiac surgery, dabigatran reduced vascular events without increasing major bleeding. Annals of internal medicine, 2018, 10-16, Volume: 169, Issue:8 Topics: Dabigatran; Hemorrhage; Humans; Myocardial Infarction	2018
Dabigatran Versus Rivaroxaban for Secondary Stroke Prevention in Patients with Atrial Fibrillation Rehabilitated in Skilled Nursing Facilities. Drugs & aging, 2018, Volume: 35, Issue:12 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Male; Medicare; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Rivaroxaban; Secondary Prevention; Skilled Nursing Facilities; Stroke; Thromboembolism; United States	2018
[NOAC in combination with platelet antiaggregation in both patients with coronary and peripheral arterial disease]. Lakartidningen, 2018, 12-04, Volume: 115 Topics: Acute Coronary Syndrome; Anticoagulants; Antithrombins; Cardiovascular Diseases; Coronary Artery Disease; Dabigatran; Drug Therapy, Combination; Factor Xa Inhibitors; Humans; Myocardial Infarction; Myocardial Ischemia; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Sweden; Thiazoles	2018
The Devil's in the details: Reports on reproducibility in pharmacoepidemiologic studies. Pharmacoepidemiology and drug safety, 2019, Volume: 28, Issue:5 Topics: Cohort Studies; Dabigatran; Data Interpretation, Statistical; Databases, Factual; Myocardial Infarction; Pharmacoepidemiology; Product Surveillance, Postmarketing; Propensity Score; Reproducibility of Results; United States; United States Food and Drug Administration; Warfarin	2019
Comparative effectiveness and safety of low-strength and high-strength direct oral anticoagulants compared with warfarin: a sequential cohort study. BMJ open, 2019, 05-05, Volume: 9, Issue:5 Topics: Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Australia; Comparative Effectiveness Research; Dabigatran; Databases, Factual; Female; Hemorrhage; Humans; Logistic Models; Male; Myocardial Infarction; Propensity Score; Pyrazoles; Pyridones; Rivaroxaban; Stroke; Veterans; Warfarin	2019
Shared parameter model for competing risks and different data summaries in meta-analysis: Implications for common and rare outcomes. Research synthesis methods, 2020, Volume: 11, Issue:1 Topics: Administration, Oral; Algorithms; Anticoagulants; Asymptomatic Infections; Atrial Fibrillation; Computer Simulation; Dabigatran; Hemorrhage; Humans; Likelihood Functions; Meta-Analysis as Topic; Motivation; Myocardial Infarction; Odds Ratio; Proportional Hazards Models; Randomized Controlled Trials as Topic; Risk Factors; Stroke; Treatment Outcome; Warfarin	2020
Economic appraisal of dabigatran as first-line therapy for stroke prevention in atrial fibrillation. South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2013, Feb-15, Volume: 103, Issue:4 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Drug Costs; Female; Humans; International Normalized Ratio; Male; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; South Africa; Stroke; Warfarin	2013
Efficacy and safety of dabigatran etexilate and warfarin in "real-world" patients with atrial fibrillation: a prospective nationwide cohort study. Journal of the American College of Cardiology, 2013, Jun-04, Volume: 61, Issue:22 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Atrial Fibrillation; Benzimidazoles; Dabigatran; Denmark; Dose-Response Relationship, Drug; Drug Prescriptions; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Hospitalization; Humans; Incidence; Intracranial Hemorrhages; Logistic Models; Male; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Prospective Studies; Pulmonary Embolism; Pyridines; Registries; Stroke; Warfarin	2013
The use, misuse and abuse of dabigatran. The Medical journal of Australia, 2013, Apr-15, Volume: 198, Issue:7 Topics: Advertising; Anticoagulants; Antithrombins; Aspirin; Australia; Benzimidazoles; beta-Alanine; Cardiovascular Diseases; Dabigatran; Drug Interactions; Drug Therapy, Combination; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Platelet Aggregation Inhibitors; Randomized Controlled Trials as Topic; Renal Insufficiency; Research Design; Selection Bias; Stroke; Warfarin	2013
Is there really misuse and abuse of dabigatran? The Medical journal of Australia, 2013, Apr-15, Volume: 198, Issue:7 Topics: Anticoagulants; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Hemorrhage; Humans; Myocardial Infarction; Patient Selection; Product Surveillance, Postmarketing; Randomized Controlled Trials as Topic; Research Design; Stroke; Warfarin	2013
Acute management of ST-elevation myocardial infarction patients taking dabigatran. The Canadian journal of cardiology, 2013, Volume: 29, Issue:11 Topics: Aged; Antithrombins; Benzimidazoles; beta-Alanine; Coronary Artery Disease; Dabigatran; Drug-Eluting Stents; Humans; Male; Myocardial Infarction; Percutaneous Coronary Intervention; Platelet Aggregation Inhibitors	2013
[Extrapolation of physiopathological data to clinical practice: Example of dabigatran in off-label use]. Presse medicale (Paris, France : 1983), 2014, Volume: 43, Issue:4 Pt 1 Topics: Administration, Oral; Aged; Antithrombins; Benzimidazoles; beta-Alanine; Contraindications; Dabigatran; Drug Substitution; Early Termination of Clinical Trials; Female; Heart Valve Prosthesis Implantation; Hemorrhage; Humans; Male; Middle Aged; Mitral Valve; Myocardial Infarction; Off-Label Use; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Stroke; Thromboembolism; Vitamin K	2014
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation. An indirect comparison analysis. Thrombosis and haemostasis, 2014, May-05, Volume: 111, Issue:5 Topics: Administration, Oral; Aged; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Clinical Trials, Phase III as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Precision Medicine; Pyrazoles; Pyridines; Pyridones; Randomized Controlled Trials as Topic; Rivaroxaban; Stroke; Survival Analysis; Thiazoles; Thiophenes; Treatment Outcome	2014
Lessons from the RE-ALIGN trial. Archives of cardiovascular diseases, 2014, Volume: 107, Issue:5 Topics: Aged; Anticoagulants; Benzimidazoles; Bioprosthesis; Clinical Trials, Phase II as Topic; Dabigatran; Heart Valve Prosthesis; Hemorrhage; Humans; Myocardial Infarction; Postoperative Complications; Pyridines; Randomized Controlled Trials as Topic; Risk; Stroke; Thromboembolism; Warfarin	2014
Adherence to dabigatran therapy and longitudinal patient outcomes: insights from the veterans health administration. American heart journal, 2014, Volume: 167, Issue:6 Topics: Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; Female; Hemorrhage; Humans; Longitudinal Studies; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Myocardial Infarction; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome; United States; United States Department of Veterans Affairs	2014
Myocardial infarction complicated by left ventricular thrombus and fatal thromboembolism following abrupt cessation of dabigatran. BMJ case reports, 2014, Jul-04, Volume: 2014 Topics: Aged, 80 and over; Angiography; Antithrombins; Benzimidazoles; beta-Alanine; Dabigatran; Fatal Outcome; Heart Diseases; Heart Ventricles; Humans; Male; Mesenteric Artery, Superior; Myocardial Infarction; Thromboembolism; Thrombosis; Tomography, X-Ray Computed	2014
[Cost-effectiveness of apixaban compared to other new oral anticoagulants in patients with non-valvular atrial fibrillation]. Kardiologiia, 2014, Volume: 54, Issue:7 Topics: Administration, Oral; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Blood Coagulation; Cost-Benefit Analysis; Dabigatran; Drug Monitoring; Hemorrhage; Humans; Models, Statistical; Morpholines; Myocardial Infarction; Prognosis; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Russia; Stroke; Thiophenes; Warfarin	2014
Non-vitamin K antagonist oral anticoagulation agents in anticoagulant naïve atrial fibrillation patients: Danish nationwide descriptive data 2011-2013. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2015, Volume: 17, Issue:2 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Comorbidity; Dabigatran; Denmark; Female; Heart Failure; Humans; Male; Middle Aged; Morpholines; Myocardial Infarction; Myocardial Ischemia; Practice Patterns, Physicians'; Pyrazoles; Pyridones; Registries; Renal Insufficiency, Chronic; Rivaroxaban; Sex Factors; Stroke; Thiophenes; Warfarin	2015
Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. Journal of medical economics, 2015, Volume: 18, Issue:6 Topics: Anticoagulants; Atrial Fibrillation; Cost-Benefit Analysis; Costs and Cost Analysis; Dabigatran; Health Expenditures; Hemorrhage; Humans; Models, Econometric; Myocardial Infarction; Pulmonary Embolism; Pyrazoles; Pyridines; Pyridones; Rivaroxaban; Stroke; Thiazoles; United States; Venous Thromboembolism; Warfarin	2015
Effectiveness and safety of dabigatran and warfarin in real-world US patients with non-valvular atrial fibrillation: a retrospective cohort study. Journal of the American Heart Association, 2015, Apr-10, Volume: 4, Issue:4 Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Humans; Male; Middle Aged; Myocardial Infarction; Propensity Score; Retrospective Studies; Stroke; United States; Warfarin	2015
Effects of Dabigatran on the Resolution of Left Ventricular Thrombus after Acute Myocardial Infarction. Internal medicine (Tokyo, Japan), 2015, Volume: 54, Issue:14 Topics: Aged; Antithrombins; Chest Pain; Dabigatran; Echocardiography; Humans; Male; Myocardial Infarction; Myocardial Reperfusion; Thrombosis; Treatment Outcome; Ventricular Dysfunction, Left	2015
Acenocoumarol vs. low-dose dabigatran in real-world patients discharged after ischemic stroke. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2016, Volume: 27, Issue:2 Topics: Acenocoumarol; Aged; Aged, 80 and over; Antithrombins; Atrial Fibrillation; Brain Ischemia; Dabigatran; Drug Administration Schedule; Female; Humans; Male; Myocardial Infarction; Patient Discharge; Prospective Studies; Stroke; Survival Analysis; Thrombosis	2016
A comparison of the safety and effectiveness of dabigatran and warfarin in non-valvular atrial fibrillation patients in a large healthcare system. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Disease-Free Survival; Drug Evaluation; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Humans; Insurance Coverage; Kaplan-Meier Estimate; Male; Middle Aged; Military Personnel; Mortality; Myocardial Infarction; Propensity Score; Proportional Hazards Models; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Safety and effectiveness of dabigatran and warfarin in routine care of patients with atrial fibrillation. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Brain Ischemia; Cerebral Hemorrhage; Comorbidity; Dabigatran; Databases, Factual; Drug Evaluation; Embolism; Factor Xa Inhibitors; Female; Follow-Up Studies; Hemorrhage; Hospitalization; Humans; Insurance Coverage; Male; Middle Aged; Myocardial Infarction; Polypharmacy; Propensity Score; Retrospective Studies; Stroke; Thrombophilia; Treatment Outcome; Warfarin; Young Adult	2015
Cardiovascular, Bleeding, and Mortality Risks of Dabigatran in Asians With Nonvalvular Atrial Fibrillation. Stroke, 2016, Volume: 47, Issue:2 Topics: Aged; Aged, 80 and over; Anticoagulants; Antithrombins; Asian People; Atrial Fibrillation; Brain Ischemia; Cardiovascular Diseases; Case-Control Studies; Dabigatran; Databases, Factual; Female; Gastrointestinal Hemorrhage; Hemorrhage; Hospitalization; Humans; Intracranial Hemorrhages; Logistic Models; Male; Middle Aged; Mortality; Myocardial Infarction; Proportional Hazards Models; Risk Factors; Stroke; Taiwan; Warfarin	2016
A real world data of dabigatran etexilate: multicenter registry of oral anticoagulants in nonvalvular atrial fibrillation. Journal of thrombosis and thrombolysis, 2016, Volume: 42, Issue:3 Topics: Aged; Anticoagulants; Atrial Fibrillation; Dabigatran; Dyspepsia; Female; Follow-Up Studies; Gastrointestinal Hemorrhage; Humans; Intracranial Hemorrhages; Male; Myocardial Infarction; Registries; Stroke; Warfarin	2016
Use of Chronic Oral Anticoagulation and Associated Outcomes Among Patients Undergoing Percutaneous Coronary Intervention. Journal of the American Heart Association, 2016, 10-17, Volume: 5, Issue:10 Topics: Aged; Aged, 80 and over; Angina Pectoris; Anticoagulants; Atrial Fibrillation; Comorbidity; Dabigatran; Databases, Factual; Female; Hospital Mortality; Humans; Kaplan-Meier Estimate; Length of Stay; Logistic Models; Male; Middle Aged; Myocardial Infarction; Odds Ratio; Patient Readmission; Percutaneous Coronary Intervention; Postoperative Hemorrhage; Propensity Score; Proportional Hazards Models; Pyrazoles; Pyridones; Risk Factors; Rivaroxaban; Stents; Stroke; Thrombosis; Venous Thromboembolism; Warfarin	2016
Comparative effectiveness of dabigatran and rivaroxaban versus warfarin for the treatment of non-valvular atrial fibrillation. Journal of cardiology, 2017, Volume: 69, Issue:6 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Dabigatran; Female; Gastrointestinal Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Rivaroxaban; Warfarin	2017
Dabigatran enhances platelet reactivity and platelet thrombin receptor expression in patients with atrial fibrillation. Journal of thrombosis and haemostasis : JTH, 2017, Volume: 15, Issue:3 Topics: Administration, Oral; Aged; Anticoagulants; Arachidonic Acid; Atrial Fibrillation; Blood Platelets; Collagen; Cross-Sectional Studies; Dabigatran; Female; Flow Cytometry; Gene Expression Regulation; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Platelet Aggregation; Receptors, Thrombin; Regression Analysis; Risk Factors; Thrombin	2017
Net clinical benefit of dabigatran vs. warfarin in venous thromboembolism: analyses from RE-COVER Journal of thrombosis and thrombolysis, 2017, Volume: 43, Issue:4 Topics: Adult; Aged; Clinical Trials as Topic; Dabigatran; Female; Hemorrhage; Humans; Male; Middle Aged; Myocardial Infarction; Pulmonary Embolism; Stroke; Venous Thromboembolism; Venous Thrombosis; Warfarin	2017
Dabigatran versus warfarin in patients with atrial fibrillation. The New England journal of medicine, 2009, Dec-31, Volume: 361, Issue:27 Topics: Anticoagulants; Aspirin; Atrial Fibrillation; Benzimidazoles; Dabigatran; Drug Therapy, Combination; Humans; Myocardial Infarction; Platelet Activation; Platelet Aggregation Inhibitors; Pyridines; Warfarin	2009
The influence of direct thrombin inhibitors on the formation of platelet-leukocyte aggregates and tissue factor expression. Thrombosis research, 2010, Volume: 126, Issue:4 Topics: Antithrombins; Azetidines; Benzimidazoles; Benzylamines; beta-Alanine; Blood Platelets; Cell-Derived Microparticles; Dabigatran; Gene Expression; Humans; Leukocytes; Myocardial Infarction; Platelet Activation; Platelet Aggregation; RNA, Messenger; Thromboplastin	2010
Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation. Annals of internal medicine, 2011, Jan-04, Volume: 154, Issue:1 Topics: Aged; Aged, 80 and over; Anticoagulants; Atrial Fibrillation; Benzimidazoles; beta-Alanine; Cost-Benefit Analysis; Dabigatran; Fibrinolytic Agents; Hemorrhage; Humans; Intracranial Hemorrhages; Ischemic Attack, Transient; Markov Chains; Myocardial Infarction; Quality-Adjusted Life Years; Risk Factors; Sensitivity and Specificity; Stroke; Warfarin	2011
Newly identified events in the RE-LY trial. The New England journal of medicine, 2010, Nov-04, Volume: 363, Issue:19 Topics: Anticoagulants; Atrial Fibrillation; Benzimidazoles; Cardiovascular Diseases; Dabigatran; Embolism; Hemorrhage; Humans; Myocardial Infarction; Pyridines	2010
Redemption by RE-DEEM? European heart journal, 2011, Volume: 32, Issue:22 Topics: Acute Coronary Syndrome; Benzimidazoles; beta-Alanine; Dabigatran; Female; Fibrinolytic Agents; Humans; Male; Myocardial Infarction; Platelet Aggregation Inhibitors	2011
Important data after drug approval: comment on "Dabigatran association with higher risk of acute coronary events". Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Myocardial Infarction; Thromboembolism	2012
Dabigatran: do we have sufficient data?: comment on "Dabigatran association with higher risk of acute coronary events". Archives of internal medicine, 2012, Mar-12, Volume: 172, Issue:5 Topics: Acute Coronary Syndrome; Benzimidazoles; beta-Alanine; Dabigatran; Female; Humans; Male; Myocardial Infarction; Thromboembolism	2012
Anticoagulant loses its lustre. Lancet (London, England), 2012, Jan-28, Volume: 379, Issue:9813 Topics: Anticoagulants; Benzimidazoles; beta-Alanine; Dabigatran; Humans; Myocardial Infarction; Stroke	2012
Cost-effectiveness of dabigatran etexilate for stroke prevention in non-valvular atrial fibrillation. Applying RE-LY to clinical practice in Denmark. Journal of medical economics, 2012, Volume: 15, Issue:4 Topics: Aged; Antithrombins; Atrial Fibrillation; Benzimidazoles; Cost-Benefit Analysis; Dabigatran; Denmark; Female; Humans; Male; Models, Theoretical; Myocardial Infarction; Pyridines; Risk Assessment; Stroke; Warfarin	2012